Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 265714, 6 pages
http://dx.doi.org/10.1155/2012/265714
Research Article

Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells

Department of Otorhinolaryngology, Shiga University of Medical Science, Seta, Tsukinowa, Otsu, Shiga 520-2192, Japan

Received 16 January 2012; Revised 27 February 2012; Accepted 2 March 2012

Academic Editor: Kazuhito Asano

Copyright © 2012 Takeshi Shimizu and Shino Shimizu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kudoh, A. Azuma, M. Yamamoto, T. Izumi, and M. Ando, “Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1829–1832, 1998. View at Google Scholar · View at Scopus
  2. T. Shirai, A. Sato, and K. Chida, “Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity,” Internal Medicine, vol. 34, no. 6, pp. 469–474, 1995. View at Google Scholar · View at Scopus
  3. K. Oishi, F. Sonoda, S. Kobayashi et al., “Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases,” Infection and Immunity, vol. 62, no. 10, pp. 4145–4152, 1994. View at Google Scholar · View at Scopus
  4. K. Fujita, T. Shimizu, Y. Majima, and Y. Sakakura, “Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells,” European Archives of Oto-Rhino-Laryngology, vol. 257, no. 4, pp. 199–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Yamada, S. Fujieda, S. Mori, H. Yamamoto, and H. Saito, “Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage,” American Journal of Rhinology, vol. 14, no. 3, pp. 143–148, 2000. View at Google Scholar · View at Scopus
  6. T. Shimizu, S. Shimizu, R. Hattori, E. C. Gabazza, and Y. Majima, “In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 5, pp. 581–587, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Takahashi, T. Shimizu, and Y. Sakakura, “Effects of indomethacin, dexamethasone, and erythromycin on endotoxin- induced intraepithelial mucus production of rat nasal epithelium,” Annals of Otology, Rhinology and Laryngology, vol. 106, no. 8, pp. 683–687, 1997. View at Google Scholar · View at Scopus
  8. T. Shimizu, H. Hirano, Y. Majima, and Y. Sakakura, “A mechanism of antigen-induced mucus production in nasal epithelium sensitized rats: a comparison with lipopolysaccharide-induced mucus production,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1648–1654, 2000. View at Google Scholar · View at Scopus
  9. T. Shimizu, Y. Takahashi, S. Kawaguchi, and Y. Sakakura, “Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 4, pp. 1412–1418, 1996. View at Google Scholar · View at Scopus
  10. S. Usui, T. Shimizu, K. Fujita, C. Kishioka, and Y. Sakakura, “Secretory cell differentiation and mucus secretion in cultures of human nasal epithelial cells: use of a monoclonal antibody to study human nasal mucin,” Annals of Otology, Rhinology and Laryngology, vol. 109, no. 3, pp. 271–277, 2000. View at Google Scholar · View at Scopus
  11. J. Tamaoki, K. Takeyama, I. Yamawaki, M. Kondo, and K. Konno, “Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides,” American Journal of Physiology, vol. 272, no. 1, pp. L15–L19, 1997. View at Google Scholar · View at Scopus
  12. Y. Cai, D. Chai, R. Wang, N. Bai, B. B. Liang, and Y. Liu, “Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systemic review,” Journal of Antimicrobial Chemotherapy, vol. 66, pp. 968–978, 2011. View at Google Scholar
  13. R. K. Albert, J. Connett, W. C. Bailey et al., “Azithromycin for prevention of exacerbations of COPD,” The New England Journal of Medicine, vol. 365, pp. 689–698, 2011. View at Google Scholar
  14. S. G. Gerhardt, J. F. McDyer, R. E. Girgis, J. V. Conte, S. C. Yang, and J. B. Orens, “Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 1, pp. 121–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Beigelman, S. Gunsten, C. L. Mikols et al., “Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma,” Chest, vol. 136, no. 2, pp. 498–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. I. Criqui, C. Solomon, B. S. Welch, R. E. Ferrando, H. A. Boushey, and J. R. Balmes, “Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release,” European Respiratory Journal, vol. 15, no. 5, pp. 856–862, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Geudens, L. Timmermans, H. Vanhooren et al., “Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury,” Transplant International, vol. 21, no. 7, pp. 688–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Beigelman, C. L. Mikols, S. P. Gunsten, C. L. Cannon, S. L. Brody, and M. J. Walter, “Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis,” Respiratory Research, vol. 11, article 90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. C. Tsai, M. L. Rodriguez, K. S. Young et al., “Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 12, pp. 1331–1339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Feola, B. A. Garvy, T. J. Cory et al., “Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, pp. 2437–2447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yamasawa, K. Oshikawa, S. Ohno, and Y. Sugiyama, “Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release,” American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 4, pp. 569–575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Perez-Martinez and D. Haas, “Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and Rsm Z in Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 55, pp. 3399–3405, 2011. View at Google Scholar
  23. H. Ishimoto, H. Mukae, N. Sakamoto et al., “Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin,” Journal of Antimicrobial Chemotherapy, vol. 63, no. 1, pp. 109–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Imamura, K. Yanagihara, Y. Mizuta et al., “Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 9, pp. 3457–3461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Araki, K. Yanagihara, Y. Morinaga et al., “Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells,” European Journal of Pharmacology, vol. 644, no. 1–3, pp. 209–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Morinaga, K. Yanagihara, N. Miyashita et al., “Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells,” Pulmonary Pharmacology and Therapeutics, vol. 22, no. 6, pp. 580–586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Lu, H. Liu, and J. M. Farley, “Macrolide antibiotics inhibit mucus secretion and calcium entry in swine airway submucosal mucous gland cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 1, pp. 178–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Ermert, C. Pantazis, H. R. Duncker, F. Grimminger, W. Seeger, and L. Ermert, “In situ localization of TNFα/β, TACE AND TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue,” Cytokine, vol. 22, no. 3-4, pp. 89–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. H. Kim, E. J. Jeon, S. N. Park, K. H. Park, Y. S. Park, and S. W. Yeo, “Effects of a tumor necrosis factor-α antagonist on experimentally induced rhinosinusitis,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 360457, 9 pages, 2011. View at Publisher · View at Google Scholar
  30. H. Yoshida and T. Furuta, “Tissue penetration properties of macrolide antibiotics-comparative tissue distribution of erythromycin-stearate, clarithromycin, roxythromycin and azithromycin in rats,” Japanese Journal of Antibiotics, vol. 52, pp. 497–503, 1999. View at Google Scholar